People: DURECT Corp (DRRX.O)

DRRX.O on Consolidated Issue listed on NASDAQ Global Market

6 May 2015
Change (% chg)

$-0.01 (-0.44%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Theeuwes, Felix 

Dr. Felix Theeuwes is Chairman, Chief Scientific Officer of DURECT Corp. He co-founded DURECT in February 1998 and has served as our Chairman and Chief Scientific Officer since July 1998. Prior to that, Dr. Theeuwes held various positions at ALZA Corporation, including President of New Ventures from August 1997 to August 1998, President of ALZA Research and Development from 1995 to August 1997, President of ALZA Technology Institute from 1994 to April 1995 and Chief Scientist from 1982 to June 1997. Dr. Theeuwes holds a D.Sc. degree in Physics from the University of Leuven (Louvain), Belgium. He also served as a post-doctoral fellow and visiting research assistant professor in the Department of Chemistry at the University of Kansas and has completed the Stanford Executive Program.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
248,221 -- 359,900 608,121

Options Compensation

  Quantity Market Value
Exercisable 248,700 444,201.00
Unexercisable 381,300 897,050.00
Exercised 32,750 85,805.00
Name Fiscal Year Total

Felix Theeuwes


James Brown


Matthew Hogan


Judy Joice


David Hoffmann


Simon Benito

As Of  30 Dec 2013
Search Stocks